Interaction between isoniazid and diverse vasodilators: Role of decreased cerebral GABA

Cardiovascular Research

Volumn 37, Issue 3, 1998, Pages 748-755

  De Los Angeles Sánchez Salvatori, María ^a   Ríos, Camilo ^b   Vidrio, Horacio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Bradycardia; Hypotension; Isoniazid; Rat; Vasodilator

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CAPTOPRIL; CHLORALOSE; DIPYRIDAMOLE; GLUTAMIC ACID; GLYCINE; HYDRALAZINE; ISONIAZID; MINOXIDIL; PAPAVERINE; PINACIDIL; PRAZOSIN; TAURINE; URETHAN; VASODILATOR AGENT; VERAPAMIL;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CONTROLLED STUDY; CROSS REACTION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG MEGADOSE; HEART RATE; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CAPTOPRIL; DIPYRIDAMOLE; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; GUANIDINES; HEART RATE; HYDRALAZINE; HYPOTHALAMUS; ISONIAZID; MALE; MINOXIDIL; PINACIDIL; PONS; PRAZOSIN; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 3042736025     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00264-2     Document Type: Article

References (37)

1. [1] Vidrio H. Potentiation of cardiovascular responses to hydralazine by diverse hydrazine derivatives. J Pharmacol Exp Ther 1994;271:171-175.
2. 6 enzymes by convulsant hydrazides. J Pharmacol Exp Ther 1957;119:255-262.
3. [3] Horton RW, Chapman AG, Meldrum BS. The convulsant action of hydrazides and regional changes in cerebral γ-aminobutyric acid and pyridoxal phosphate concentrations. J Neurochem 1979;33:745-749.
4. [4] Biggs CS, Pearce BR, Fowler LJ, Whitton PS. Effect of isonicotinic acid hydrazide on extracellular amino acids and convulsions in the rat. Reversal of neurochemical and behavioral deficits by sodium valproate. J Neurochem 1994;63:2197-2201.
5. [5] Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems: Part 1. General considerations. Experientia 1986;42:109-210.
6. [6] Sved AF, Curtis JT. Amino acid neurotransmitters in nucleus tractus solitarius. An in vivo microdialysis study. J Neurochem 1993;61:2089-2098.
7. [7] van der Heyden JAM, Korf J. Regional levels of GABA in the brain. Rapid semiautomated assay and prevention of postmortem increase by 3-mercaptopropionic acid. J Neurochem 1978;31:197-203.
8. [8] Jones BN, Paabo S, Stein S. Amino acid analysis and enzymatic sequence determination of peptides by an improved o-phthaldialdehyde precolumn labelling procedure. J Liq Chromatogr 1981;4:565-586.
9. [9] Lugnier C, Bertrand Y, Stoclet JC. Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation. Eur J Pharmacol 1972;19:134-136.
10. [10] Chang KC, Chong WS, Lee IJ. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine and GS 389, on isolated rat aorta and heart. Can J Physiol Pharmacol 1994;72:327-334.
11. [11] Du Charme DW, Freyburger WA, Graham BE, Carlson RG. Pharmacological properties of minoxidil: a new hypotensive agent. J Pharmacol Exp Ther 1973;184:662-670.
12. [12] Johnson GA, Barsuhn KJ, McCall JM. Sulfation of minoxidil by liver sulfotransferase. Biochem Pharmacol 1982;31:2949-2954.
13. [13] Rechtman M, Majewski H. A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig. Br J Pharmacol 1993;110:289-296.
14. [14] Bousquet P, Feldman J, Schwartz J. GABA et régulation centrale de la fonction cardiovasculaire. J Pharmacol Paris 1985;16(2):29-50.
15. [15] Abshire VM, Hankins KD, Roehr KE, Di Micco JA. Injection of L-allylglycine into posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate. Neuropharmacology 1980;27:1171-1177.
16. [16] Shonis CA, Peano CA, Dillon GH, Waldrop TG. Cardiovascular responses to blockade of GABA synthesis in the hypothalamus of the spontaneously hypertensive rat. Brain Res Bull 1993;31:493-499.
17. [17] Bousquet P, Feldman J, Bloch R, Schwartz J. Evidence for a neuromodulatory role of GABA at the first synapse of the baroreceptor reflex pathway. Effects of GABA derivatives injected into the NTS. Naunyn Schmiedebergs Arch Pharmacol 1982;319:168-171.
18. [18] Blessing WW, Reis DJ. Evidence that GABA and glycine-like inputs inhibit vasodepressor neurons in the caudal ventrolateral medulla of the rabbit. Neurosci Lett 1983;37:57-62.
19. [19] Wood JD, Kurylo E. Amino acid content of nerve endings (synaptosomes) in different regions of brain. Effects of gabaculine and isonicotinic acid hydrazide. J Neurochem 1984;42:420-425.
20. [20] Kihara M, Kubo T. Effect of hydralazine-induced hypotension on glutamate, γ-aminobutyric acid and some other amino acid levels in medullary regions of the rat. Arch Int Pharmacodyn 1989;299:86-97.
21. [21] Kubo H, Kihara M, Misu Y. Hypotension decreases GABA levels in brainstem regions of the rat. Clin Exp Hypertens (A) 1990; 12:317-324.
22. [22] Singewald N, Schneider C, Philippu A. Disturbances in blood pressure homeostasis modify GABA release in the locus coeruleus. Neuroreport 1994;5:1709-1712.
23. [23] Kimura T, Funyu T, Ohta M, Yamamoto T, Oka K, Shoji M, Inoue M, Sato K, Abe K. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes. J Auton Nerv Syst 1994;50:21-29.
24. [24] Singewald N, Philippu A. Involvement of biogenic amines and amino acids in the central regulation of cardiovascular homeostasis. Trends Pharmacol Sci 1996;17:356-363.
25. [25] Unger P, Berkenboom G, Fontaine J. Interaction between hydralazine and nitrovasodilators in vascular smooth muscle. J Cardiovasc Pharmacol 1993;21:478-483.
26. [26] Hirai S, Kotake H, Kurata Y, Hisatome Y, Hasegawa J, Mashiba H. Effect of pinacidil on the electrophysiological properties in guineapig papillary muscle and rabbit sino-atrial node. J Pharm Pharmacol 1990;42:339-343.
27. [27] Sanguinetti MC, West TC. Influence of papaverine on spontaneous activity of isolated right atria from small mammals. J Pharmacol Exp Ther 1984;228:500-509.
28. [28] Sopena M, Brugger A, Salvá JA. Estudio experimental sobre el mecanismo de acción bradicardizante del dipiridamol. Rev Clin Esp 1969;114:473-480.
29. [29] Pagliaro P, Gatullo D, Merletti A, Losano G, Marsh NA. Heart rate decrease after inhibition of nitric oxide release in the anaesthetized dog. Boll Soc Ital Biol Sper 1995;71:75-81.
30. [30] Paakkari Y, Puurunen J. Vagally mediated bradycardiac effect of prazosin in anaesthetized rats. Eur J Pharmacol 1984;105:223-228.
31. [31] Vidrio H, García-Márquez F. Reversal by hypothermia of vasodilator-induced tachycardia in anesthetized rats. Arch Int Pharmacodyn 1987;288:217-228.
32. [32] Di Micco JA, Gale K, Hamilton B, Gillis RA. GABA receptor control of parasympathetic outflow to heart. Characterization and brainstem localization. Science 1979;204:1106-1109.
33. [33] Di Micco JA, Alsip NL, Wible JH. Multiple roles for CNS GABA mechanisms in the autonomic regulation of cardiovascular function. Pharmacologic evidence. Neuropharmacology 1984;23:819-820.
34. [34] Bauer RM, Vela MB, Simon T, Waldrop TG. A GABAergic mechanism in the posterior hypothalamus modulates baroreflex bradycardia. Brain Res Bull 1988;20:633-641.
35. [35] Pinelli A, Trivulzio S, Colombo-Zefinetti G, Tofanetti O. Anti-convulsant effects by reduced glutathione and related aminoacids in rats treated with isoniazid. Toxicology 1988;48:103-107.
36. [36] Perry TL, Hansen S. Sustained drug-induced elevation of brain GABA in the rat. J Neurochem 1973;21:1167-1175.
37. [37] Manyam BV, Ferraro TN, Hare TA. Isoniazid-induced alterations of CSF neurotransmitter amino acids in Huntington's disease. Brain Res 1987;408:125-130.